Compare Rush Street Interactive Inc (RSI) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs BIO-TECHNE Corp — how do they compare? Rush Street Interactive Inc trades at $20.26 (market cap $2.35B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.36B). The key difference: BIO-TECHNE Corp is far larger — about 4.8× Rush Street Interactive Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rush Street Interactive Inc for 13 Days and BIO-TECHNE Corp for 63 Days on average.
| RSI | TECH | |
|---|---|---|
Market Cap | $2.35B | $11.36B |
Volume | 2,219,374 | 5,390,331 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.52 | $72.61 |
52-Week Low | $15.89 | $43.31 |
Typical Hold Time | 13 Days | 63 Days |
Enterprise Value | $2.01B | $11.39B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RSI trades at $20.24, down 1.56% amid bearish technical signals, though analyst consensus remains strongly bullish with a $34.88 price target. The company shows revenue growth to $1.13B in 2025 with expanding EBITDA margins, but faces valuation concerns with a P/E of 65.29. Recent Q2 2026 earnings beat expectations with $0.15 EPS, while institutional interest grows with BlackRock's $448M investment in August 2026.
The stock presents a growth opportunity with strong analyst support and institutional backing, but high valuation multiples and bearish technical indicators suggest near-term volatility. Execution on revenue growth and margin expansion will be critical to justify current premium pricing amid competitive online gambling market pressures.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $1.22B, with a net income margin of 14.97%. Valuation ratios are elevated, with a P/E of 62.46 and P/S of 9.36. A significant development is the shareholder-approved acquisition by Merck KGaA at $73.00 per share, pending completion.
The outlook is heavily influenced by the pending acquisition, offering a near-term price ceiling. Fundamentals show solid profitability but high valuation multiples. Risks include acquisition deal completion uncertainty and integration challenges. Analyst sentiment is mixed with no sell ratings, but the consensus price target of $65.78 suggests limited upside from current levels, making the stock a hold pending acquisition closure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
